Jeff Yass’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Jeff Yass’s Portfolio UBIO Stock Details UBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,400	Closed	-$271K	–	10426
2016 Q3	$271K	Sell	9,400 -3,400	-27%	-$96.8K	﹤0.01%	7099
2016 Q2	$271K	Buy	+12,800	New	+$324K	﹤0.01%	7119

Other funds holding UBIO

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Jeff Yass's UBIO Position: Q1 2020 in Review

Jeff Yass sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 33,955 shares — an estimated $1.11M sold.

Jeff Yass first reported a position in UBIO in Q4 2015 and held it in 12 quarters. The position peaked at $1.3M in Q4 2015. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.

Jeff Yass reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
Jeff Yass sold 33,955 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $1.11M.
Jeff Yass first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 12 quarters.
Jeff Yass's Proshares UltraPro NASDAQ Biotechnology position peaked at $1.3M in Q4 2015.
1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.